Genome-wide association study identifies three new melanoma susceptibility loci

Nature Genetics

Volumn 43, Issue 11, 2011, Pages 1108-1113

  Barrett, Jennifer H ^a   Iles, Mark M ^a   Harland, Mark ^a   Taylor, John C ^a   Aitken, Joanne F ^b   Andresen, Per Arne ^c   Akslen, Lars A ^d,e   Armstrong, Bruce K ^f   Avril, Marie Francoise ^g   Azizi, Esther ^h   Bakker, Bert ⁱ   Bergman, Wilma ⁱ   Bianchi Scarrà, Giovanna ^j   Bressac De Paillerets, Brigitte ^k,l   Calista, Donato ^m   Cannon Albright, Lisa A ⁿ   Corda, Eve ^k   Cust, Anne E ^o,p   Dȩbniak, Tadeusz ^q   Duffy, David ^r   Dunning, Alison M ^s   Easton, Douglas F ^s   Friedman, Eitan ^h   Galan, Pilar ^t   Ghiorzo, Paola ^j   Giles, Graham G ^o,u   Hansson, Johan ^v   Hocevar, Marko ^w   Höiom, Veronica ^v   Hopper, John L ^o   Ingvar, Christian ^x   Janssen, Bart ^x,y   Jenkins, Mark A ^o   Jönsson, Göran ^x   Kefford, Richard F ^f   Landi, Giorgio ^m   Landi, Maria Teresa ^z   Lang, Julie ^aa   Lubiński, Jan ^q   MacKie, Rona ^aa   Malvehy, Josep ^ab   Martin, Nicholas G ^r   Molven, Anders ^d,e   Montgomery, Grant W ^r   Van Nieuwpoort, Frans A ⁱ   Novakovic, Srdjan ^w   Olsson, Håkan ^x   Pastorino, Lorenza ^j   Puig, Susana ^ab,ac   Puig Butille, Joan Anton ^ab,ac   Randerson Moor, Juliette ^a   Snowden, Helen ^a   Tuominen, Rainer ^v   Van Belle, Patricia ^ad   Van Der Stoep, Nienke ⁱ   Whiteman, David C ^r   Zelenika, Diana ^ae   Han, Jiali ^af,ag   Fang, Shenying ^ah   Lee, Jeffrey E ^ah   Wei, Qingyi ^ah   Lathrop, G Mark ^k,ae   Gillanders, Elizabeth M ^ai   Brown, Kevin M ^z   Goldstein, Alisa M ^z   Kanetsky, Peter A ^aj   Mann, Graham J ^f   MacGregor, Stuart ^r   Elder, David E ^ad   Amos, Christopher I ^ah   Hayward, Nicholas K ^r   Gruis, Nelleke A ⁱ   Demenais, Florence ^k,ak   Bishop, Julia A Newton ^a   Bishop, D Timothy ^a   more..

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f WESTMEAD HOSPITAL   (Australia)

^g Université Descartes ^*  (France)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF GENOA   (Italy)

^k FONDATION JEAN DAUSSET CEPH   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m BUFALINI HOSPITAL   (Italy)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF MELBOURNE   (Australia)

^p UNIVERSITY OF SYDNEY   (Australia)

^q POMERANIAN MEDICAL UNIVERSITY   (Poland)

^r QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t Queensland Institute of Medical Research ^*  (France)

^u CANCER EPIDEMIOLOGY CENTRE   (Australia)

^v KAROLINSKA INSTITUTE   (Sweden)

^w INSTITUTE OF ONCOLOGY   (Slovenia)

^x LUND UNIVERSITY HOSPITAL   (Sweden)

^y ServiceXS   (Netherlands)

^z NATIONAL CANCER INSTITUTE   (United States)

^aa UNIVERSITY OF GLASGOW   (United Kingdom)

^ab UNIVERSITY OF BARCELONA   (Spain)

^ac INSTITUTO DE SALUD CARLOS III   (Spain)

^ad UNIVERSITY OF PENNSYLVANIA   (United States)

^ae CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^af BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ag HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ah UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^ai NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^aj UNIVERSITY OF PENNSYLVANIA   (United States)

^ak UNIVERSITÉ PARIS DIDEROT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; EUROPE; FRANCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MELANOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS;

EID: 80054996042     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.959     Document Type: Article

References (35)

1. Cannon-Albright, L.A., Bishop, D.T., Goldgar, C. & Skolnick, M.H. Genetic predisposition to cancer. Important Adv. Oncol. 39-55 (1991).
2. Naldi, L. et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann. Epidemiol. 15, 545-550 (2005). (Pubitemid 40982131)
3. Titus-Ernstoff, L. et al. Pigmentary characteristics and moles in relation to melanoma risk. Int. J. Cancer 116, 144-149 (2005). (Pubitemid 40827768)
4. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am. J. Epidemiol. 141, 923-933 (1995).
5. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am. J. Epidemiol. 141, 934-942 (1995).
6. Bataille, V. et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer 73, 1605-1611 (1996). (Pubitemid 26235392)
7. Chang, Y.M. et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int. J. Cancer 124, 420-428 (2009).
8. Bishop, D.T. et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41, 920-925 (2009).
9. Raimondi, S. et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 122, 2753-2760 (2008). (Pubitemid 351631377)
10. Kanetsky, P.A. et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 66, 9330-9337 (2006). (Pubitemid 44521156)
11. Gudbjartsson, D.F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886-891 (2008). (Pubitemid 351913649)
12. Falchi, M. et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat. Genet. 41, 915-919 (2009).
13. Brown, K.M. et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40, 838-840 (2008). (Pubitemid 351913651)
14. Duffy, D.L. et al. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. Am. J. Hum. Genet. 87, 6-16 (2010).
15. Duffy, D.L. et al. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J. Invest. Dermatol. 130, 520-528 (2010).
16. Guedj, M. et al. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Hum. Mutat. 29, 1154-1160 (2008).
17. Nan, H., Kraft, P., Hunter, D.J. & Han, J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int. J. Cancer 125, 909-917 (2009).
18. Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41, 221-227 (2009).
19. Han, J. et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4, e1000074 (2008).
20. Fernandez, L.P. et al. SLC45A2: a novel malignant melanoma-associated gene. Hum. Mutat. 29, 1161-1167 (2008).
21. Baird, D.M. Variation at the TERT locus and predisposition for cancer. Expert Rev. Mol. Med. 12, e16 (2010).
22. Yin, M., Yan, J., Wei, S. & Wei, Q. CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis 31, 850-857 (2010).
23. Lavin, M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9, 759-769 (2008).
24. Garner, C. Upward bias in odds ratio estimates from genome-wide association studies. Genet. Epidemiol. 31, 288-295 (2007). (Pubitemid 46642093)
25. Curtin, J.A. et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135-2147 (2005). (Pubitemid 41653105)
26. Newton-Bishop, J.A. et al. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom. Cancer Epidemiol. Biomarkers Prev. 19, 2043-2054 (2010).
27. Pruim, R.J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
28. Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
29. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006). (Pubitemid 44141658)
30. Clayton, D. Testing for association on the X chromosome. Biostatistics 9, 593-600 (2008).
31. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002). (Pubitemid 34746062)
32. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177-188 (1986). (Pubitemid 17189972)
33. Newton-Bishop, J.A. et al. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur. J. Cancer 47, 732-741 (2011).
34. Newton-Bishop, J.A. et al. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 27, 5439-5444 (2009).
35. Gauderman, W.J. & Morrison, J.M. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-Epidemiology Studies. (2006). Available from http://hydra.usc.edu/gxe.